The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight
- PMID: 17199730
- DOI: 10.1111/j.1463-1326.2006.00582.x
The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
